Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
Aim: To study indices of energy metabolism, content of K+ and Mg++ both in peripheral blood and in Walker-256 carcinosarcoma during development of resistance to doxorubicin. Methods: Resistance of Walker-256 carcinosarcoma to doxorubicin has been developed through 12 subsequent transplantations of t...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2015 |
| Main Authors: | Todor, I.N., Lukianova, N.Yu., Shvets, Yu.V., Lozovska, Yu.V., Chekhun, V.F. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2015
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/145449 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin / I.N. Todor, N.Yu. Lukianova, Yu.V. Shvets, Yu.V. Lozovska, V.F. Chekhun // Experimental Oncology. — 2015. — Т. 37, № 1. — С. 19-22. — Бібліогр.: 19 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
by: Boroday, N.V., et al.
Published: (2018)
by: Boroday, N.V., et al.
Published: (2018)
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: I. N. Todor, et al.
Published: (2015)
by: I. N. Todor, et al.
Published: (2015)
Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
by: Chekhun, V.F., et al.
Published: (2018)
by: Chekhun, V.F., et al.
Published: (2018)
Metalloproteins during development of Walker-256 carcinosarcoma resistant phenotype
by: V. F. Chekhun, et al.
Published: (2015)
by: V. F. Chekhun, et al.
Published: (2015)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
The influence of lactoferrin on elemental homeostasis and activity of metal-containing enzymes in rats with Walker-256 carcinosarcoma
by: Lozovska, Yu.V., et al.
Published: (2023)
by: Lozovska, Yu.V., et al.
Published: (2023)
Change of morphostructural characteristics and metabolic profile of Walker-256 carcinosarcoma under the impact of exogenous lactoferrin
by: L. A. Nalieskina, et al.
Published: (2020)
by: L. A. Nalieskina, et al.
Published: (2020)
Magnetic nanotherapy of animals with carcinosarcoma Walker-256
by: V. E. Orel, et al.
Published: (2014)
by: V. E. Orel, et al.
Published: (2014)
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009)
by: Lukyanova, N.Yu., et al.
Published: (2009)
Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: Burlaka, A.P., et al.
Published: (2015)
by: Burlaka, A.P., et al.
Published: (2015)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: Chekhun, V.F., et al.
Published: (2014)
by: Chekhun, V.F., et al.
Published: (2014)
Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
by: Rusetskaya, N.V., et al.
Published: (2009)
by: Rusetskaya, N.V., et al.
Published: (2009)
Pharmacological effect of aminoferrocene in mice with L1210 leukemia
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
In vitro modification of cisplatin cytotoxicity with magnetic fluid
by: Chekhun, V.F., et al.
Published: (2013)
by: Chekhun, V.F., et al.
Published: (2013)
Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatin
by: Naleskina, L.A., et al.
Published: (2013)
by: Naleskina, L.A., et al.
Published: (2013)
Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)
by: Rusetskaya, N.V., et al.
Published: (2011)
Proinflammatory effects of photoactivated methylene blue on rat model of Walker 256 carcinosarcoma
by: Petrellis, M.C., et al.
Published: (2023)
by: Petrellis, M.C., et al.
Published: (2023)
Comparative study of dye-loaded liposome accumulation in sensitive and resistant human breast cancer cells
by: Yefimova, S.L., et al.
Published: (2012)
by: Yefimova, S.L., et al.
Published: (2012)
Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Structural changes of serum albumin in response to oxidative stress caused by Walker-256 carcinosarcoma growth
by: Sarnatskaya, V.V., et al.
Published: (2023)
by: Sarnatskaya, V.V., et al.
Published: (2023)
Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicinsensitive transplantable rhabdomyosarcoma
by: Belova, O.B., et al.
Published: (2007)
by: Belova, O.B., et al.
Published: (2007)
Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticles
by: Yurchenko, O.V., et al.
Published: (2010)
by: Yurchenko, O.V., et al.
Published: (2010)
Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model
by: Zykova, M.G., et al.
Published: (2012)
by: Zykova, M.G., et al.
Published: (2012)
Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factor
by: Shevchuk, O.O., et al.
Published: (2015)
by: Shevchuk, O.O., et al.
Published: (2015)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010)
by: Lukyanova, N.Yu.
Published: (2010)
Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
by: Potebnya, G.P., et al.
Published: (2009)
by: Potebnya, G.P., et al.
Published: (2009)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Modifying effects of 5-azacytidine on metal-containing proteins profile in guerin carcinoma with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
The use of nanoferromagnetics to increase the cytotoxic effect of antitumor drugs
by: Chekhun, V.F., et al.
Published: (2009)
by: Chekhun, V.F., et al.
Published: (2009)
Gold nanoparticles synthesis and biological activity estimation in vitro and in vivo
by: Rieznichenko, L.S., et al.
Published: (2012)
by: Rieznichenko, L.S., et al.
Published: (2012)
Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
by: Zadvornyi, T.V., et al.
Published: (2018)
by: Zadvornyi, T.V., et al.
Published: (2018)
The state of bone metabolism in lung cancer patients
by: Dumansky, Y.V., et al.
Published: (2018)
by: Dumansky, Y.V., et al.
Published: (2018)
Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells
by: Pan, Y.Y., et al.
Published: (2007)
by: Pan, Y.Y., et al.
Published: (2007)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Similar Items
-
Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
by: Boroday, N.V., et al.
Published: (2018) -
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: I. N. Todor, et al.
Published: (2015) -
Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
by: Chekhun, V.F., et al.
Published: (2018) -
Metalloproteins during development of Walker-256 carcinosarcoma resistant phenotype
by: V. F. Chekhun, et al.
Published: (2015) -
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)